p190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland

Molecular Endocrinology

Volumn 20, Issue 6, 2006, Pages 1391-1405

  Vargo Gogola, Tracy ^a   Heckman, Brandy M ^a   Gunther, Edward J ^b   Chodosh, Lewis A ^c   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P190; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPERPLASIA; MACROPHAGE; MAMMARY GLAND; MORPHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PHENOTYPE; PREGNANCY; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 33744469039     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0426     Document Type: Article

References (38)

1. Bissell MJHH 1987 Form and function in the mammary gland: the role of extracellular matrix. New York: Plenum Publishing Corp.
2. Hinck LaS, Gary B 2005 The mammary end bud as a motile organ. Breast Cancer Res 7:245-251
3. Fata JE, Werb Z, Bissell MJ 2004 Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6:1-11
4. Parmar H, Cunha GR 2004 Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr Relat Cancer 11:437-458
5. Karnoub AE, Symons M, Campbell SL, Der CJ 2004 Molecular basis for Rho GTPase signaling specificity. Breast Cancer Res Treat 84:61-71
6. Lin M, van Golen KL 2004 Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Res Treat 84:49-60
7. Burbelo PD, Miyamoto S, Utani A, Brill S, Yamada KM, Hall A, Yamada Y 1995 p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking. J Biol Chem 270:30919-30926
8. Rihet S, Vielh P, Camonis J, Goud B, Chevillard S, de Gunzburg J 2001 Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors. J Cancer Res Clin Oncol 127:733-738
9. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD 1999 A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5:2511-2519
10. Fritz G, Just I, Kaina B 1999 Rho GTPases are overexpressed in human tumors. Int J Cancer 81:682-687
11. Burbelo P, Wellstein A, Pestell RG 2004 Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat 84:43-48
12. Chakravarty G, Roy D, Gonzales M, Gay J, Contreras A, Rosen JM 2000 P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer. Cell Growth Differ 2000 11:343-354
13. Chakravarty G, Hadsell D, Buitrago W, Settleman J, Rosen JM 2003 p190-B RhoGAP regulates mammary ductal morphogenesis. Mol Endocrinol 17:1054-1065
14. Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD, Cardiff RD, Chodosh LA 2003 Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 17:488-501
15. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA 2002 A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 16:283-292
16. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM 2005 Tensional homeostasis and the malignant phenotype. Cancer Cell 8:241-254
17. Gouon-Evans V, Rothenberg ME, Pollard JW 2000 Postnatal mammary gland development requires macrophages and eosinophils. Development 127:2269-2282
18. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS 2000 Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 204:19-28
19. Sordella R, Classon M, Hu K-Q, Matheson SF, Brouns MR, Fine F, Zhang L, Takami H, Yamada Y, Settleman J 2002 Modulation of CREB activity by the Rho GTPase determines cell size during embryonic development. Dev Cell 2:553-565
20. Bonnette SG, Hadsell DL 2001 Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-4945
21. Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW 2005 Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65:3781-3787
22. Simpson KJ, Dugan AS, Mercurio AM 2004 Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64:8694-8701
23. Pille JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H 2005 Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11:267-274
24. Wiseman BS, Werb Z 2002 Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049
25. Daniel CW, Silberstein GB, Strickland P 1987 Direct action of 17 β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 47:6052-6057
26. Deugnier MA, Teuliere J, Faraldo MM, Thiery JP, Glukhova MA 2002 The importance of being a myoepithelial cell. Breast Cancer Res 4:224-230
27. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH 1997 The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3:1949-1958
28. Nguyen M, Lee MC, Wang JL, Tomlinson JS, Shao ZM, Alpaugh ML, Barsky SH 2000 The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19:3449-3459
29. Barsky SH 2003 Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol 74:113-122
30. Welm B, Freeman K, Chen M, Contreras A, Spencer D, Rosen J 2002 Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol 157:703-714
31. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ 2003 ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163:583-595
32. Settleman J 2001 Rac 'n Rho: the music that shapes a developing embryo. Dev Cell 1:321-331
33. Stanley ER, Berg KL, Einstein DB, Lee PS, Yeung YG 1994 The biology and action of colony stimulating factor-1. Stem Cells 12(Suppl 1):15-24; discussion 25
34. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW 2002 The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7:147-162
35. Sordella R, Jiang W, Chen GC, Curto M, Settleman J 2003 Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113:147-158
36. Deome KB, Faulkin Jr LJ, Bern HA, Blair PB 1959 Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19:515-520
37. Rijnkels M, Rosen JM 2001 Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. J Cell Sci 114:3147-3153
38. Church GM, Gilbert W 1984 Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995